ERIBULIN MESILATE
Eribulin mesilate is a microtubule inhibitor used in metastatic breast cancer. Side effects include fatigue, neutropenia, and neuropathy.
About MedicaPharma
MedicaPharma distributes high-quality active pharmaceutical ingredients (APIs) to hospitals, commercial (compounding) pharmacies, research institutes, and universities worldwide.
Network of over +400 GMP API producers
Let us handle your sourcing / supply activities. Highly experienced in sourcing specialty raw pharmaceutical ingredients from niche GMP manufacturers around the world.
Why Choose MedicaPharma
Niche API specialist - Pro-active supply partner - High service level - Global network - Logistics according to GDP regulations
Product Description
Mechanism of Action
Eribulin mesilate is a synthetic analogue of halichondrin B that binds to the plus ends of microtubules, inhibiting polymerization without affecting depolymerization. This causes irreversible mitotic blockade in G2–M, followed by apoptotic cell death. It also remodels tumor vasculature and may reverse epithelial–mesenchymal transition.
Benefits and Advantages
Used in microtubule‑dynamics studies, antimitotic‑drug modelling, metastatic‑progression research, and cytoskeletal‑targeted cancer assays.
Side Effects and Risks
Risks include neutropenia, peripheral neuropathy, alopecia, QT prolongation and myelosuppression. Handle with cytotoxic antimicrotubule‑agent precautions.
Datasheet
| Molecular Formula | C41H63NO14S |
|---|---|
| Molecular Weight | 826.0 g/mol |
| CAS Number | 441045-17-6 |
| Storage Condition | Store in a cool, dry place. Keep container tightly closed. Protect from moisture and light. |
| Solubility | Solubility depends on solvent and conditions (e.g., pH). Please contact us for solvent-specific guidance. |
| Purity | Purity information is available upon request (COA). |
| Synonym | Eribulin mesylate; 441045-17-6; Halaven; Eribulin mesilate; Eribulin (as mesylate) |
| IUPAC/Chemical Name | (1S,3S,6S,9S,12S,14R,16R,18S,20R,21R,22S,26R,29S,31R,32S,33R,35R,36S)-20-[(2S)-3-amino-2-hydroxypropyl]-21-methoxy-14-methyl-8,15-dimethylidene-2,19,30,34,37,39,40,41-octaoxanonacyclo[24.9.2.13,32.13,33.16,9.112,16.018,22.029,36.031,35]hentetracontan-24-one;methanesulfonic acid |
| InChl Key | QAMYWGZHLCQOOJ-WRNBYXCMSA-N |
| InChl Code | InChI=1S/C40H59NO11.CH4O3S/c1-19-11-24-5-7-28-20(2)12-26(45-28)9-10-40-17-33-36(51-40)37-38(50-33)39(52-40)35-29(49-37)8-6-25(47-35)13-22(42)14-27-31(16-30(46-24)21(19)3)48-32(34(27)44-4)15-23(43)18-41;1-5(2,3)4/h19,23-39,43H,2-3,5-18,41H2,1,4H3;1H3,(H,2,3,4)/t19-,23+,24+,25-,26+,27+,28+,29+,30-,31+,32-,33-,34-,35+,36+,37+,38-,39+,40+;/m1./s1 |
| References |
3D Conformer.
(Click, turn or enlarge)
Download our GMP API Product List.
MedicaPharma is an EU-based supplier of GMP-certified APIs that serves leading healthcare institutions and research organizations.
Click here to download our full API product list.
